Dose-ranging trials measure whether group-level outcomes change across assigned amounts. Retatrutide Phase 2 results showed a pattern of greater mean weight reduction in higher target groups.
Weight outcomes and tolerability
Researchers also track adverse events, discontinuation and other outcomes. A larger weight change may be accompanied by a different tolerability profile.
How to interpret the evidence
Compare both outcomes and harms across the randomized arms before interpreting dose response. These comparisons are inputs to research design.
This series reports assigned research arms for interpreting study results. Retatrutide is investigational, and clinical-trial amounts are not dosing instructions.